In response to the National Patient Safety Agency Rapid Response Report published in October 2011, midwives involved in the care of pregnant women at risk of having a baby with Medium Chain Acyl-coA Dehydrogenase Deficiency (MCADD) are now able to access free elearning.
This specially designed MCADD elearning session will keep midwives up to date with the latest evidence based practice. During the 25 minute session they will learn about identfication of pregnancies at risk of MCADD and also the care of the newborn ‘at risk’ of MCADD.
This resource is the result of a collaboration of leading professional experts in this field together with the NHS National Genetic Education and Development Centre and the UK National Newborn Screening Committee.
1 in 10,000 people have Medium Chain Acyl-coA Dehydrogenase Deficiency (MCADD) an inherited metabolic disorder caused by a genetic change in the MCAD gene. MCADD results in the lack of, or malfunction of an enzyme that converts stored fat (medium chain fatty acids) into energy. MCADD is screened for at birth.